Provided by Tiger Fintech (Singapore) Pte. Ltd.

BridgeBio Pharma, Inc.

38.40
+0.04000.10%
Post-market: 38.540.1400+0.36%17:44 EDT
Volume:4.72M
Turnover:179.61M
Market Cap:7.29B
PE:-10.86
High:38.62
Open:38.29
Low:36.85
Close:38.36
Loading ...

BridgeBio Pharma First Quarter 2025 Earnings: Beats Expectations

Simply Wall St.
·
Yesterday

BridgeBio Pharma Stock (BBIO) Jumps on Strong Drug Launch

TIPRANKS
·
Yesterday

Why BridgeBio Pharma, Inc. (BBIO) Surged on Wednesday

Insider Monkey
·
Yesterday

Q1 2025 BridgeBio Pharma Inc Earnings Call

Thomson Reuters StreetEvents
·
Yesterday

BridgeBio Pharma Is Maintained at Buy by UBS

Dow Jones
·
30 Apr

BridgeBio price target raised to $55 from $52 at Scotiabank

TIPRANKS
·
30 Apr

BridgeBio price target raised to $72 from $65 at UBS

TIPRANKS
·
30 Apr

BridgeBio Pharma Shares up 6.1% After Q1 Sales of Heart Condition Drug Beat Estimates

THOMSON REUTERS
·
30 Apr

UBS Adjusts Price Target on BridgeBio Pharma to $72 From $65, Maintains Buy Rating

MT Newswires Live
·
30 Apr

BridgeBio price target raised to $50 from $46 at BofA

TIPRANKS
·
30 Apr

S&P 500 Futures Fall In Premarket Trading; Super Micro Computer, ICL Group Lag

Dow Jones
·
30 Apr

Scotiabank Keeps Their Buy Rating on BridgeBio Pharma (BBIO)

TIPRANKS
·
30 Apr

Wells Fargo Sticks to Their Buy Rating for BridgeBio Pharma (BBIO)

TIPRANKS
·
30 Apr

BridgeBio Pharma Shares up 9.6% Premarket After Q1 Sales of Heart Condition Drug Beat Estimates

THOMSON REUTERS
·
30 Apr

Stock Track | BridgeBio Pharma Surges 9.61% Pre-market on Strong Q1 Earnings, Beating Revenue Estimates

Stock Track
·
30 Apr

BridgeBio Pharma Inc (BBIO) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ...

GuruFocus.com
·
30 Apr

U.S. RESEARCH ROUNDUP-Coca-Cola, Ecolab, Honeywell

Reuters
·
30 Apr

BUZZ-BridgeBio gains as Q1 sales of heart condition drug beat estimates

Reuters
·
30 Apr

BridgeBio Pharma Q1 Loss Widens, Revenue Drops

MT Newswires Live
·
30 Apr

BridgeBio Pharma Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
30 Apr